logo

Curis Inc (CRIS)



Trade CRIS now with
  Date
  Headline
8/4/2022 4:08:00 PM Curis Q2 Loss/share $0.17 Vs. Loss $0.12 Year Ago
6/10/2022 7:05:11 AM Curis Announces Presentations On Biomarker Development And Emavusertib Clinical Data At 2022 EHA Hybrid Congress
5/5/2022 4:06:08 PM Curis Q1 Loss/share $0.18 Vs. Loss $0.11 Year Ago
4/11/2022 8:03:07 AM Curis Announces FDA Partial Clinical Hold For TakeAim Lymphoma Study Of Emavusertib On B-cell Malignancies
4/4/2022 7:04:19 AM Curis Announces FDA Places Partial Clinical Hold For TakeAim Leukemia Study Of Emavusertib
2/24/2022 4:06:26 PM Curis Reports Q4 Loss Per Share Of $0.15 Vs. Loss Per Share Of $0.11 Last Year
1/6/2022 10:59:07 AM Curis Shares Down 27%
1/6/2022 7:05:22 AM Curis Reports Data With Addl Clinical Activity In Phase 1/2 Study Of CA-4948 Monotherapy In Relapsed/Refractory AML,MDS
11/9/2021 4:03:39 PM Curis Inc Q3 Earnings Summary
11/9/2021 4:03:01 PM Curis Q4 Loss/share $0.12 Vs. Loss $0.11 Year Ago